Pharmaceutical & Life Sciences News

Capsule: Health Lobbying, State Protections & Drug Policy Consensus

May 24, 2019, 9:17 AM

Welcome to Capsule—your weekly dose of health-care news, where we give you a recap of this week’s highs and lows for key players in the industry. You can expect us every Friday morning as a bookend for your week.

It was a good week for the Food and Drug Administration. A House panel passed a $184 million bump in discretionary funding from last year and $3.3 billion in discretionary funds in total. Here’s a fun fact for you: About $1.91 million of that is for rent and “related activities.” That makes me feel a tiny bit better about what I...

To read the full article log in or if you would like to request a demo visit bloombergindustry.com